Solid Biosciences (SLDB) Return on Sales (2021 - 2023)

Solid Biosciences (SLDB) has 3 years of Return on Sales data on file, last reported at 0.44% in Q1 2023.

• For the quarter ending Q1 2023, Return on Sales fell 31.0% year-over-year to 0.44%; the trailing twelve-month figure through Mar 2023 stood at 0.44% (down 27.0% YoY), and the FY2022 full-year result was 0.33%, down 18.0% from the prior year.
• Return on Sales eased to 0.44% in Q1 2023, from 0.33% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.04% in Q2 2022 to a low of 0.47% in Q4 2021.
• A 3-year average of 0.2% and a median of 0.13% in 2022 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales climbed 14 bps in 2022 and slumped 31 bps in 2023, its largest moves.
• Tracing SLDB's Return on Sales over 3 years: stood at 0.47% in 2021, then advanced by 29 bps to 0.33% in 2022, then tumbled by 34 bps to 0.44% in 2023.
• Business Quant data shows SLDB's Return on Sales at 0.44% in Q1 2023, 0.33% in Q4 2022, and 0.19% in Q3 2022.